Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DT Midstream heads into its October 29 earnings report with short sellers quietly rebuilding positions while the stock trades nearly flat on the week, a split that is worth watching as the print approaches.
Short interest has climbed fast over the past month. At 6.4% of the free float, the short position has grown 34% over thirty days, with a 13% jump in the past week alone taking shares short to roughly 6.55 million. That is a meaningful acceleration for a midstream name where fee-based contracts typically limit downside surprises. What keeps this from being a squeeze setup is the borrow market itself: availability is wide at 521%, meaning there are more than five shares available to borrow for every one already borrowed, and the cost to borrow is just 0.46%. Shorts are rebuilding with ease, not fighting a tight market. The options market is not adding much alarm either. The put/call ratio of 0.08 is only marginally above its 20-day average, and barely one standard deviation above the norm. Overall, positioning reads as directional bearishness rather than panic hedging.
The Street's recent moves tell a more cautious story than the headline consensus suggests. Morgan Stanley upgraded DTM to Overweight in mid-September, keeping its $170 target, and Wolfe Research moved to Outperform around the same time. But offsetting that, Jefferies trimmed its target from $155 to $145 in September, and Barclays shaved its Equal-Weight target from $143 to $142 earlier this month. The mean price target of around $152 implies roughly 23% upside from the current $123.67, but the direction of travel for targets has been consistently downward since mid-summer. Valuation has compressed: the PE multiple has fallen more than a point over thirty days to 24.7x, and EV/EBITDA has eased to 12.2x. The factor picture adds nuance. The dividend score ranks in the 96th percentile of DTM's universe, reflecting the company's 5-7% annual dividend growth commitment. But EPS momentum over 30 and 90 days ranks in the bottom third, and EPS surprise sits at the 39th percentile. Bulls point to the $3.4 billion organic project backlog, up 50%, and take-or-pay contract structures that shield cash flows. Bears flag $3.32 billion of debt and concentrated exposure to the Haynesville and Northeast regions.
On the ownership side, BlackRock has been adding. The manager reported 11.4 million shares at the end of September, up roughly 482,000 shares on the prior reading, and holds 11.2% of the stock. Geode Capital added over a million shares in the same period to reach 3.4 million. Passive accumulation at this scale points to index-driven buying rather than active conviction, but the flow is additive. On the insider side, CFO Jeffrey Jewell made open-market purchases at $133.78 in August and again at $136.33 in February, both small in dollar terms ($19,000 and $25,000 respectively) but both discretionary and not under a 10b5-1 plan. Director Elaine Pickle bought 1,500 shares at $132.61 in August for roughly $199,000, also discretionary. These are modest positions against the current $123.67 price, meaning all three buyers are sitting on losses. There are no activist filings of note; BlackRock and Vanguard are on the 13G register as passive holders.
The last earnings release in late July produced a 1-day move of just 1.5% followed by a 5-day move of negative 2.2%. That is a quiet pattern, with the stock consistently drifting lower in the week following results. The ORTEX short score has edged up from 50.5 to 53.6 over the past two weeks, a gentle but steady grind higher that mirrors the acceleration in short shares outstanding.
With earnings twelve days out, the question is whether the growing short position reflects a genuine conviction trade on weaker-than-expected results, or is simply the market pricing in sector-wide caution around midstream names at elevated multiples. Peer KMI is up 5.3% on the week while WMB and AM are slightly lower, suggesting the sector is not moving in a single direction, which makes DTM's flat week and rising short interest the more pointed datapoint to track into October 29.
See the live data behind this article on ORTEX.
Open DTM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
